Magnevist and Prempro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnevist (gadopentetate dimeglumine) and Prempro (estrogens, conjugated; medroxyprogesterone acetate). Common drug interactions include pain among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Magnevist and Prempro. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Magnevist?

Magnevist has active ingredients of gadopentetate dimeglumine. eHealthMe is studying from 10,524 Magnevist users. Check the latest studies of Magnevist.

What is Prempro?

Prempro has active ingredients of estrogens, conjugated; medroxyprogesterone acetate. It is often used in menopause. eHealthMe is studying from 42,950 Prempro users. Check the latest studies of Prempro.

On Jul, 17, 2026

26 people who take Magnevist and Prempro together, and have interactions are studied.

Magnevist and Prempro drug interactions.

What are the common drug interactions of Magnevist and Prempro, by gender? *:

female:

Pain
Skin hyperpigmentation (disorders affect the colour of your skin)
Oedema peripheral (superficial swelling)
General physical health deterioration (weak health status)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Skin hypertrophy (skin cells enlarges)
Skin induration (an abnormally hard spot or area on the skin)
Gait disturbance
Skin tightness
Hypoaesthesia (reduced sense of touch or sensation)

male:

Abdominal pain
Abscess limb (limb infection)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Cellulitis (infection under the skin)
Chest discomfort
Chills (felling of cold)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Constipation
Cough

What are the common drug interactions of Magnevist and Prempro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Skin hyperpigmentation (disorders affect the colour of your skin)
Gait disturbance
General physical health deterioration (weak health status)
Hypoaesthesia (reduced sense of touch or sensation)
Injury
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)

50-59:

Deformity (disfigurement)
Arthralgia (joint pain)
Gait disturbance
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
Oedema peripheral (superficial swelling)
Skin hyperpigmentation (disorders affect the colour of your skin)
Skin tightness
Abdominal pain
Abscess limb (limb infection)
Alopecia areata (patchy baldness that typically begins with rapid hair loss)

60+:

Abdominal pain
Abscess limb (limb infection)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac failure congestive
Cellulitis (infection under the skin)
Chest discomfort
Chills (felling of cold)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Constipation
Cough

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 11 people, 42.31%
Osteoporosis (bones weak and more likely to break): 8 people, 30.77%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 8 people, 30.77%
Renal Disorder (kidney disease): 4 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Magnevist and Prempro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously